Skip to main content

Grafa News and Videos — Page 916

Grafa Headlines

Latest

Grafa

Atlas Arteria chair Goodin steps down as IFM takes majority control

Atlas Arteria (ASX:ALX) has lodged a sixth supplementary target’s statement with ASIC and ASX, reiterating its independent directors’ unanimous recommendation that securityholders reject IFM Global Infrastructure Fund’s off‑market cash offer for Atlas Arteria stapled securities.

Read more: Atlas Arteria chair Goodin steps down as IFM takes majority control
Grafa

Director Trent Bowden pleads guilty to misusing $1.5m in investor funds

Former company director Trent Bowden has pleaded guilty in the Perth Magistrates Court to three charges of dishonestly using his position as director of Trent Bowden Trading Pty Ltd to gain an advantage for himself, in connection with more than $1.5 million of investor funds.

Read more: Director Trent Bowden pleads guilty to misusing $1.5m in investor funds
Grafa

CSL faces EU revocation of TAVNEOS authorisation, $145m in FY26 sales at risk

CSL Limited (ASX:CSL) has reported that the European Medicines Agency’s CHMP has issued an opinion recommending the revocation of the EU marketing authorisation for TAVNEOS (avacopan), an in‑licensed therapy sold in EU and EEA markets by CSL Vifor affiliates.

Read more: CSL faces EU revocation of TAVNEOS authorisation, $145m in FY26 sales at risk

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift